Wolfe Research analyst Mike Polark initiated coverage of Tandem Diabetes with a Peer Perform rating and $41-$48 fair value range. The analyst prefers to "watch from a safe distance" as the company looks to get its "mojo back."
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on TNDM: